Catalyst Capital Advisors LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 426.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 726 shares of the company’s stock after acquiring an additional 588 shares during the quarter. Catalyst Capital Advisors LLC’s holdings in Cardinal Health were worth $86,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently modified their holdings of CAH. Mirae Asset Global Investments Co. Ltd. lifted its position in Cardinal Health by 35.2% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock worth $3,871,000 after purchasing an additional 8,471 shares during the period. CHURCHILL MANAGEMENT Corp lifted its position in Cardinal Health by 1.5% in the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock worth $28,435,000 after purchasing an additional 3,576 shares during the period. Geode Capital Management LLC lifted its position in Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after purchasing an additional 42,082 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Cardinal Health by 2.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after purchasing an additional 33,388 shares during the period. Finally, Consolidated Planning Corp lifted its position in Cardinal Health by 40.0% in the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock worth $1,056,000 after purchasing an additional 2,552 shares during the period. 87.17% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages recently commented on CAH. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. Wells Fargo & Company increased their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $132.00 to $145.00 in a research note on Monday, January 6th. UBS Group increased their price objective on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Finally, Mizuho started coverage on Cardinal Health in a research note on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $136.87.
Cardinal Health Stock Performance
Shares of NYSE:CAH opened at $126.35 on Wednesday. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84. The firm has a market cap of $30.52 billion, a PE ratio of 23.57, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. The business has a fifty day moving average of $123.06 and a 200-day moving average of $116.74.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.60%. Cardinal Health’s dividend payout ratio is currently 37.69%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Five stocks we like better than Cardinal Health
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- 3 Monster Growth Stocks to Buy Now
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.